Please assess the completion status of the following clinical trial:

Trial Title: Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* cytologically or histologically verified anaplastic thyroid cancer~* completed standard therapy~* operated with R0 or R1 surgery~* Performance Status 0-2 (if pulmonary mets PS 0-1)~* normal wound healing~* neutrophils \> 1,5 million/ml~* platelets \> 100 million/ml~* bilirubin \< 2 ULN~* creatinin \< 150mikromol/L~Exclusion Criteria:~* PS 3-4 (if pulmonary mets 2-4)~* R2 resection of primary tumor

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- chemotherapy (Type: EXPERIMENTAL): Treatment with Avastin 15 mg/kg q3w and doxorubicin 20 mg q1w for 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).